Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

PaperCitations, authors & open-access status

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2,150 citations, 2010 year and closed oa status.

2,150
Citations
2010
Year
closed
OA Status

Related on ScholarIQ

Hubert Piessevaux
Author
The Lancet Oncology
Journal
Colorectal Cancer Treatments and Studies
Topic
Colorectal Cancer Treatments and Studies
Topic
Cancer Genomics and Diagnostics
Topic
Genetic factors in colorectal cancer
Topic
470M+ articles · free account